Back to top
more

Eli Lilly and Company (LLY)

(Delayed Data from NYSE)

 Add to portfolio

Trades from $3

$81.20 USD

81.20
9,214,807

-2.22 (-2.66%)

Updated Apr 25, 2017 04:00 PM ET

Volume: 9,214,807

Open: $82.71

Prior Close: $83.42

3-Hold     3    

Value: B | Growth: B | Momentum: A | VGM: A

The Zacks Scorecard is a complimentary set of indicators to use alongside the Zacks Rank. It allows the investor to better focus on the stocks that are the best fit for his or her personal investment style.

We produce five unique ratings, including the Zacks Style Score, which combines the individual style scores into 1 rating:

Zacks Style Score A
Growth Score A
Value Score A
Momentum Score A
Income Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a score of an A or a B in your personal trading style.

Zacks Scorecard Education - Learn more about the Zacks Scorecard

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1 Strong Buy 25.71%
2 Buy 18.12%
3 Hold 9.91%
4 Sell 5.49%
5 Strong Sell 2.29%
S&P 500 9.79%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The way to access to the Zacks Rank

The Zacks Equity Research reports, or ZER for short, are our in-house, independently produced research reports.

The ever popular one-page Snapshot reports are generated for virtually every single Zacks Ranked stock. It's packed with all of the company's key stats and salient decision making information. Including the Zacks Rank, Zacks Industry Rank, Style Scores, the Price, Consensus & Surprise chart, graphical estimate analysis and how a stocks stacks up to its peers.

The detailed multi-page Analyst report does an even deeper dive on the company's vital statistics. In addition to all of the proprietary analysis in the Snapshot, the report also visually displays the four components of the Zacks Rank (Agreement, Magnitude, Upside and Surprise); provides a comprehensive overview of the company business drivers, complete with earnings and sales charts; a recap of their last earnings report; and a bulleted list of reasons to buy or sell the stock. It also includes an industry comparison table to see how your stock compares to its expanded industry, and the S&P 500.

Researching stocks has never been so easy or insightful as with the ZER Analyst and Snapshot reports.

Learn more about Zacks Equity Research reports

See more Zacks Equity Research reports

Balance Sheet

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

Research for LLY

   

The Zacks Equity Research reports, or ZER for short, are our in-house, independently produced research reports.

The ever popular one-page Snapshot reports are generated for virtually every single Zacks Ranked stock. It's packed with all of the company's key stats and salient decision making information. Including the Zacks Rank, Zacks Industry Rank, Style Scores, the Price, Consensus & Surprise chart, graphical estimate analysis and how a stocks stacks up to its peers.

The detailed multi-page Analyst report does an even deeper dive on the company's vital statistics. In addition to all of the proprietary analysis in the Snapshot, the report also visually displays the four components of the Zacks Rank (Agreement, Magnitude, Upside and Surprise); provides a comprehensive overview of the company business drivers, complete with earnings and sales charts; a recap of their last earnings report; and a bulleted list of reasons to buy or sell the stock. It also includes an industry comparison table to see how your stock compares to its expanded industry, and the S&P 500.

Researching stocks has never been so easy or insightful as with the ZER Analyst and Snapshot reports.

Learn more about Zacks Equity Research reports

See more Zacks Equity Research reports

Fiscal Year End for Eli Lilly and Company falls in the month of December.

All items in Millions except Per Share data.

12/31/2016 12/31/2015 12/31/2014 12/31/2013 12/31/2012
Assets          
Cash & Equivalents 6,039 4,452 4,827 5,397 5,684
Receivables 4,766 4,072 3,801 4,023 3,888
Notes Receivable 0 0 0 0 0
Inventories 3,562 3,446 2,740 2,929 2,644
Other Current Assets 735 604 812 756 822
Total Current Assets 15,101 12,574 12,180 13,105 13,039
Net Property & Equipment 8,253 8,054 7,964 7,976 7,760
Investments & Advances 5,208 3,647 4,569 7,625 6,313
Other Non-Current Assets 0 0 0 0 0
Deferred Charges 0 0 0 0 0
Intangibles 8,331 9,075 4,642 4,331 4,753
Deposits & Other Assets 1,914 2,221 7,823 2,213 2,534
Total Assets 38,806 35,569 37,178 35,249 34,399
Liabilities & Shareholders Equity 12/31/2016 12/31/2015 12/31/2014 12/31/2013 12/31/2012
Notes Payable 1,937 6 2,689 1,013 12
Accounts Payable 1,349 1,338 1,128 1,119 1,188
Current Portion Long-Term Debt 0 0 0 0 0
Current Portion Capital Leases 0 0 0 0 0
Accrued Expenses 0 0 0 0 0
Income Taxes Payable 119 359 1,560 1,047 1,192
Other Current Liabilities 7,581 6,526 5,831 5,738 5,998
Total Current Liabilities 10,987 8,230 11,208 8,917 8,390
Mortgages 0 0 0 0 0
Deferred Taxes/Income 0 0 0 0 0
Convertible Debt 0 0 0 0 0
Long-Term Debt 8,368 7,972 5,368 4,200 5,519
Non-Current Capital Leases 0 0 0 0 0
Other Non-Current Liabilities 5,371 4,777 5,215 4,491 5,716
Minority Interest (Liabilities) 0 0 0 0 0
Total Liabilities 24,725 20,979 21,790 17,608 19,625
Shareholders Equity 12/31/2016 12/31/2015 12/31/2014 12/31/2013 12/31/2012
Preferred Stock 0 0 0 0 0
Common Stock (Par) 689 691 695 699 717
Capital Surplus 5,641 5,552 5,292 5,050 4,963
Retained Earnings 16,046 16,012 16,483 16,992 16,088
Other Equity -8,214 -7,575 -6,990 -5,007 -6,802
Treasury Stock 81 90 91 94 192
Total Shareholder's Equity 14,081 14,590 15,388 17,641 14,774
Total Liabilities & Shareholder's Equity 38,806 35,569 37,178 35,249 34,399
Total Common Equity 14,081 14,590 15,388 17,641 14,774
Shares Outstanding 1,103.90 1,108.00 1,113.40 1,126.60 1,160.40
Book Value Per Share 12.76 13.17 13.82 15.66 12.73

Fiscal Year End for Eli Lilly and Company falls in the month of December.

All items in Millions except Per Share data.

3/31/2017 12/31/2016 9/30/2016 6/30/2016 3/31/2016
Assets          
Cash & Equivalents NA 6,039 4,227 3,935 2,995
Receivables NA 4,766 4,521 4,493 4,187
Notes Receivable NA 0 0 0 0
Inventories NA 3,562 3,881 3,760 3,740
Other Current Assets NA 735 757 790 792
Total Current Assets NA 15,101 13,386 12,977 11,715
Net Property & Equipment NA 8,253 8,252 8,066 8,033
Investments & Advances NA 5,208 5,027 4,449 3,764
Other Non-Current Assets NA 0 0 0 0
Deferred Charges NA 0 0 0 0
Intangibles NA 8,331 8,646 8,833 8,935
Deposits & Other Assets NA 1,914 2,279 2,150 2,245
Total Assets NA 38,806 37,590 36,475 34,692
Liabilities & Shareholders Equity 3/31/2017 12/31/2016 9/30/2016 6/30/2016 3/31/2016
Notes Payable NA 1,937 642 646 648
Accounts Payable NA 1,349 1,161 1,208 1,152
Current Portion Long-Term Debt NA 0 0 0 0
Current Portion Capital Leases NA 0 0 0 0
Accrued Expenses NA 0 0 0 0
Income Taxes Payable NA 119 183 88 115
Other Current Liabilities NA 7,581 6,287 6,459 5,426
Total Current Liabilities NA 10,987 8,273 8,401 7,341
Mortgages NA 0 0 0 0
Deferred Taxes/Income NA 0 0 0 0
Convertible Debt NA 0 0 0 0
Long-Term Debt NA 8,368 8,707 8,686 7,478
Non-Current Capital Leases NA 0 0 0 0
Other Non-Current Liabilities NA 4,994 4,733 4,844
Minority Interest (Liabilities) NA 0 0 0 0
Total Liabilities NA 24,725 21,975 21,819 19,662
Shareholders Equity 3/31/2017 12/31/2016 9/30/2016 6/30/2016 3/31/2016
Preferred Stock NA 0 0 0 0
Common Stock (Par) NA 689 690 690 690
Capital Surplus NA 5,641 5,649 5,588 5,523
Retained Earnings NA 16,046 16,602 15,824 16,155
Other Equity NA -8,214 -7,244 -7,366 -7,258
Treasury Stock NA 81 81 81 81
Total Shareholder's Equity NA 14,081 15,616 14,656 15,029
Total Liabilities & Shareholder's Equity NA 38,806 37,590 36,475 34,692
Total Common Equity 0 14,081 15,616 14,656 15,029
Shares Outstanding 1,103.30 1,103.90 1,103.90 1,104.40 1,104.40
Book Value Per Share 0.00 12.76 14.15 13.27 13.61